In a complementary report by Rosenow and colleagues monitoring of CD34-lineage specific chimerism in BM was confirmed as a highly sensitive and specific diagnostic tool for the identification of AML and MDS patients at risk for hematological relapse after alloHCT (27). Here, CD34 is linked to myelodysplastic syndrome.